PRAME Predicts Metastasis in Class 1 Uveal Melanoma
PRAME mRNA expression is independent prognostic biomarker in Class 1 uveal melanoma
February 2016 Briefing – Hematology & Oncology
Here are what the editors at HealthDay consider to be the most important developments in Hematology & Oncology for February 2016. This roundup includes...
Prostate Cancer Tied to Higher Colorectal Cancer Risk
Risk highest for rectal cancer among prostate cancer patients treated with radiation
Occult Uterine Sarcomas in One in 1,124 Hysterectomies
Nine cases identified within large cohort of 10,119 hysterectomies for benign gynecologic indications
PTSD, Depression Common After Stem Cell Transplant
Decline in QOL and increase in depressive symptoms during hospitalization predict six-month outcomes
Drop-to-Drop Variation Seen With Fingerprick Blood
Authors say variation in blood analytes holds implications for point-of-care testing
Suggestions for Optimizing Practice Feedback Effectiveness
Practice feedback interventions relate to nature of desired action, feedback display, delivery of feedback
Weekly Paclitaxel Doesn’t Up Survival in Ovarian Cancer
Among patients not receiving bevacizumab, weekly paclitaxel tied to improved progression-free survival
Thirty-Six Percent Increase in Mastectomies From 2005 to 2013
Bilateral mastectomies with cancer more than tripled and those without cancer more than doubled
Researchers Say Pancreatic Cancer Is Four Separate Diseases
Findings may lead to better therapies, team says
